Get the Stockscreener App
1.622
4.02%
-0.068
Cyclerion Therapeutics Inc stock is traded at $1.622, with a volume of 18,704.
It is down -4.02% in the last 24 hours and down -36.39% over the past month.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
See More
Previous Close:
$1.69
Open:
$1.63
24h Volume:
18,704
Relative Volume:
0.06
Market Cap:
$5.41M
Revenue:
$556.00K
Net Income/Loss:
$-5.28M
P/E Ratio:
-0.7579
EPS:
-2.14
Net Cash Flow:
$-6.23M
1W Performance:
-13.26%
1M Performance:
-36.39%
6M Performance:
-52.71%
1Y Performance:
-34.33%
1-Day Range:
$1.60
$1.6692
1-Week Range:
$1.60
$1.88
52-Week Range:
$1.27
$9.4699
Cyclerion Therapeutics Inc Stock (CYCN) Company Profile
Name
Cyclerion Therapeutics Inc
Sector
Industry
Phone
617-621-7722
Address
301 BINNEY STREET, CAMBRIDGE, MA
Compare CYCN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CYCN
Cyclerion Therapeutics Inc
|
1.622 | 5.41M | 556.00K | -5.28M | -6.23M | -2.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-21 | Initiated | Truist | Buy |
| Sep-24-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-03-19 | Initiated | Credit Suisse | Neutral |
Cyclerion Therapeutics Inc Stock (CYCN) Latest News
Combining machine learning predictions for Cyclerion Therapeutics Inc.2025 Performance Recap & Advanced Technical Analysis Signals - newser.com
How to monitor Cyclerion Therapeutics Inc. with trend dashboardsForecast Cut & Daily Technical Forecast Reports - newser.com
Live market analysis of Cyclerion Therapeutics Inc.Short Setup & Fast Gain Stock Trading Tips - newser.com
Why Cyclerion Therapeutics Inc. stock is a value investor pickTrade Analysis Report & Low Risk Profit Maximizing Plans - fcp.pa.gov.br
Why Cyclerion Therapeutics Inc. stock is recommended by analystsMarket Risk Summary & Safe Swing Trade Setup Alerts - newser.com
Is Cyclerion Therapeutics Inc. stock recession proofQuarterly Market Review & High Return Trade Opportunity Guides - newser.com
What institutional flow reveals about Cyclerion Therapeutics Inc.July 2025 Decliners & Low Drawdown Investment Strategies - newser.com
Smart tools for monitoring Cyclerion Therapeutics Inc.’s price actionJuly 2025 Technicals & Community Trade Idea Sharing Platform - newser.com
Will Cyclerion Therapeutics Inc. stock recover faster than marketMarket Risk Summary & Low Volatility Stock Suggestions - fcp.pa.gov.br
Will Cyclerion Therapeutics Inc. stock maintain growth storyEarnings Growth Summary & Entry and Exit Point Strategies - newser.com
How Cyclerion Therapeutics Inc. stock valuations compare to rivals2025 Technical Overview & Risk Managed Investment Strategies - fcp.pa.gov.br
What MACD and RSI say about Cyclerion Therapeutics Inc.July 2025 Short Interest & Risk Controlled Swing Alerts - newser.com
Is Cyclerion Therapeutics Inc. stock a top pick in earnings season2025 Trading Volume Trends & Short-Term Trading Opportunity Alerts - fcp.pa.gov.br
Comparing Cyclerion Therapeutics Inc. in custom built stock radarsMarket Growth Review & Fast Exit and Entry Trade Guides - newser.com
Tick level data insight on Cyclerion Therapeutics Inc. volatilityIPO Watch & Risk Controlled Swing Alerts - newser.com
Is Cyclerion Therapeutics Inc. stock reversal real or fake2025 Market Outlook & Verified Short-Term Trading Plans - newser.com
Can Cyclerion Therapeutics Inc. stock double in next 5 yearsQuarterly Earnings Report & Weekly Breakout Watchlists - fcp.pa.gov.br
Short interest data insights for Cyclerion Therapeutics Inc.Insider Buying & AI Enhanced Trade Execution Alerts - newser.com
What high frequency data says about Cyclerion Therapeutics Inc.Options Play & Low Volatility Stock Recommendations - newser.com
How Cyclerion Therapeutics Inc. stock performs after earnings2025 Geopolitical Influence & Free Long-Term Investment Growth Plans - fcp.pa.gov.br
Should you hold or exit Cyclerion Therapeutics Inc. nowJuly 2025 Final Week & Free Community Consensus Stock Picks - newser.com
How resilient is Cyclerion Therapeutics Inc. stock in market downturns2025 Market Sentiment & Free Verified High Yield Trade Plans - fcp.pa.gov.br
Published on: 2025-11-03 08:27:32 - newser.com
Is Cyclerion Therapeutics Inc. stock entering bullish territoryTrade Volume Report & Reliable Intraday Trade Alerts - newser.com
Cyclerion Therapeutics Inc Stock (CYCN) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.44%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):